nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A semi-automated, isotope-dilution high-resolution mass spectrometry assay for therapeutic drug monitoring of antidepressants
|
Lindner, Johanna M. |
|
2019 |
4-5 |
PB |
p. 89-98 |
artikel |
2 |
A simplified and sensitive immunoprecipitation mass spectrometry protocol for the analysis of amyloid-beta peptides in brain tissue
|
Richard, B.C. |
|
2019 |
4-5 |
PB |
p. 83-88 |
artikel |
3 |
Association of PTHrP levels in CSF with Alzheimer’s disease biomarkers
|
Kushnir, Mark M. |
|
2019 |
4-5 |
PB |
p. 124-129 |
artikel |
4 |
Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse®) using oral fluid as specimen
|
Böttcher, Michael |
|
2019 |
4-5 |
PB |
p. 99-105 |
artikel |
5 |
Detection and characterization of TDP-43 in human cells and tissues by multiple reaction monitoring mass spectrometry
|
Pobran, Taylor D. |
|
2019 |
4-5 |
PB |
p. 66-73 |
artikel |
6 |
Detection of in utero Exposure to Cannabis in Paired Umbilical Cord Tissue and Meconium by Liquid Chromatography-Tandem Mass Spectrometry
|
Jensen, Triniti L. |
|
2019 |
4-5 |
PB |
p. 115-123 |
artikel |
7 |
Editorial Board
|
|
|
2019 |
4-5 |
PB |
p. ii |
artikel |
8 |
Leveraging the power of mass spectrometry to unravel complex brain pathologies
|
Bergquist, Jonas |
|
2019 |
4-5 |
PB |
p. 63-65 |
artikel |
9 |
Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency
|
Aoki, Kazuhiro |
|
2019 |
4-5 |
PB |
p. 106-114 |
artikel |
10 |
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease
|
Hansson, Karl |
|
2019 |
4-5 |
PB |
p. 74-82 |
artikel |